Literature DB >> 25723826

Treating pulmonary silicosis by blocking interleukin 1.

Giulio Cavalli1, Federico Fallanca, Charles A Dinarello, Lorenzo Dagna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25723826     DOI： 10.1164/rccm.201412-2150LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

1.  Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance.

Authors:  Giulio Cavalli; Jamie N Justice; Kristen E Boyle; Angelo D'Alessandro; Elan Z Eisenmesser; Jonathan J Herrera; Kirk C Hansen; Travis Nemkov; Rinke Stienstra; Cecilia Garlanda; Alberto Mantovani; Douglas R Seals; Lorenzo Dagna; Leo A B Joosten; Dov B Ballak; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

Review 2.  A toxicological profile of silica nanoparticles.

Authors:  James Y Liu; Christie M Sayes
Journal:  Toxicol Res (Camb)       Date:  2022-07-16       Impact factor: 2.680

3.  The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease.

Authors:  Greta Pacini; Giulio Cavalli; Alessandro Tomelleri; Giacomo De Luca; Guido Pacini; Marina Ferrarini; Claudio Doglioni; Lorenzo Dagna
Journal:  Oncoimmunology       Date:  2018-03-15       Impact factor: 8.110

4.  Inflammasome-Independent Leukotriene B4 Production Drives Crystalline Silica-Induced Sterile Inflammation.

Authors:  Bindu Hegde; Sobha R Bodduluri; Shuchismita R Satpathy; Ruqaih S Alghsham; Venkatakrishna R Jala; Silvia M Uriarte; Dong-Hoon Chung; Matthew B Lawrenz; Bodduluri Haribabu
Journal:  J Immunol       Date:  2018-04-02       Impact factor: 5.422

5.  Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report.

Authors:  Laura Niccoli; Emanuele Cassarà; Olga Kaloudi; Carlotta Nannini; Micaela Romagnoli; Fabrizio Cantini
Journal:  BMC Musculoskelet Disord       Date:  2015-06-14       Impact factor: 2.362

6.  Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure.

Authors:  Giulio Cavalli; Marco Foppoli; Luca Cabrini; Charles A Dinarello; Moreno Tresoldi; Lorenzo Dagna
Journal:  Front Immunol       Date:  2017-02-09       Impact factor: 7.561

7.  Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.

Authors:  Alessandro Tomelleri; Giulio Cavalli; Giacomo De Luca; Corrado Campochiaro; Teresa D'Aliberti; Moreno Tresoldi; Lorenzo Dagna
Journal:  Front Immunol       Date:  2018-06-01       Impact factor: 7.561

8.  Myocarditis: An Interleukin-1-Mediated Disease?

Authors:  Giacomo De Luca; Giulio Cavalli; Corrado Campochiaro; Moreno Tresoldi; Lorenzo Dagna
Journal:  Front Immunol       Date:  2018-06-13       Impact factor: 7.561

9.  Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.

Authors:  Giulio Cavalli; Giacomo De Luca; Corrado Campochiaro; Emanuel Della-Torre; Marco Ripa; Diana Canetti; Chiara Oltolini; Barbara Castiglioni; Chiara Tassan Din; Nicola Boffini; Alessandro Tomelleri; Nicola Farina; Annalisa Ruggeri; Patrizia Rovere-Querini; Giuseppe Di Lucca; Sabina Martinenghi; Raffaella Scotti; Moreno Tresoldi; Fabio Ciceri; Giovanni Landoni; Alberto Zangrillo; Paolo Scarpellini; Lorenzo Dagna
Journal:  Lancet Rheumatol       Date:  2020-05-07

Review 10.  Cell-Based Therapy for Silicosis.

Authors:  Miquéias Lopes-Pacheco; Elga Bandeira; Marcelo M Morales
Journal:  Stem Cells Int       Date:  2016-03-15       Impact factor: 5.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.